Mesenteric ischemia results from insufficient blood flow to the intestines and has a high mortality rate, primarily due to delayed diagnosis. It is classified into acute (AMI) and chronic (CMI) forms, ...
For retired grandfather Ed Langevin, life was good. He spent plenty of time with his grandkids. He went to church regularly. And he loved the simple things, like a bowl of pasta or a sub from his ...
SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ...
Mark W. Feinberg, MD, cardiologist with the Mass General Brigham Heart and Vascular Institute and professor of medicine at Harvard Medical School, is the senior author of a paper published in the ...
This media is in the public domain (free of copyright restrictions). You can copy, modify, and distribute this work without contacting the Smithsonian. For more ...
This media is in the public domain (free of copyright restrictions). You can copy, modify, and distribute this work without contacting the Smithsonian. For more ...
Stress testing results—no matter the modality used to obtain them—predict prognosis among patients with stable, moderate-to-severe CAD, new data from the ISCHEMIA trial suggest. The study, published ...
Ischemic Colitis occurs when blood flow to part of the colon is reduced or blocked, causing inflammation and potential tissue damage. Symptoms can range from mild abdominal discomfort to severe pain ...
For stable patients with chronic total occlusion (CTOs), treatment with an invasive strategy that includes coronary revascularization does not reduce the risk of cardiovascular death or myocardial ...
Increase in NAION associated with semaglutide use among individuals with type 2 diabetes. (HealthDay News) — For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly ...
New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset. In the HOPE trial, administration of intravenous (IV) ...
Semaglutide exposure was significantly associated with a higher incidence rate and independently predicted a higher risk for upcoming nonarteritic anterior ischemic optic neuropathy. HealthDay News — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback